AdhereHealth asks why the prescription never became a habit

Mr. Brooks needed his blood-pressure medicine. He also needed a way to get it. In a patient account published by AdhereHealth, the 65-year-old had diabetes, hypertension, glaucoma and severe vision loss. Food and reliable transport were in short supply. A refill reminder would have arrived at a household with rather more pressing logistical concerns.

The missing ride

AdhereHealth’s rules engine flagged an adherence risk and an overdue diabetic retinal exam. An outreach clinician discovered the transport and food problems, connected Mr. Brooks with food assistance, enrolled him in prescription delivery, and arranged an exam with transport through his health plan. The company says he regained access to his medicine and completed the exam. His name was changed for privacy.

That account offers a useful way into the company. A missed refill looks wonderfully tidy in a database. The household behind it can be complicated. Here, the operational failure lay between identifying a need and making the next step possible. More information about the medicine would have left the missing ride exactly where it was.

AdhereHealth occupies that awkward space. It works for health plans and organizations that bear healthcare costs, bringing together software and people who can coordinate with members, providers and pharmacies. The practical ambition is to make a treatment plan survive contact with everyday life.

A pharmacist’s view of the hospital business

The company began in 2006 as PharmMD. Its founder, the late Clayton McWhorter, had trained as a pharmacist before becoming chief executive of HCA. According to the company’s history, his brother Fred encouraged him to establish the business to reduce medication complications. Someone who understood both prescriptions and hospitals could see the expensive territory between them.

In March 2019, PharmMD became AdhereHealth. The announcement tied the name to medication adherence and the removal of social barriers. It also described software, engagement services and home-delivered pharmacy working together. The change expressed a broader view of the job: the medicine mattered, and so did the conditions that allowed someone to obtain and use it.

At the time, the company reported working with seven of the ten largest health plans and reaching nearly ten million consumers through its platform. Those were 2019 figures. They describe organizational reach, rather than ten million people receiving a personal call. Scale in healthcare deserves its nouns.

The work after the risk score

The Adhere Platform supplies the analytical machinery. Published materials describe daily analysis of pharmacy claims and other inputs, including eligibility, quality, discharge and social-determinants data. The point is to prioritize an action: which member needs attention, which gap matters, and what the outreach team should investigate next.

Medication optimization adds another useful comparison. By aligning medical and pharmacy claims, AdhereHealth looks for a diagnosis without a corresponding fill, as well as problems with continued medication use. Its workflows support medication reviews and the resolution of drug therapy problems. The software supplies a clue; a clinician still has to establish what the clue means.

This puts the company in a crowded but consequential market. Outcomes offers pharmacy-based medication therapy management and patient engagement. Medecision supplies broader data and care-management workflows. A health plan can also build around its own staff. These are overlapping alternatives. AdhereHealth’s proposition combines the analytical work, member engagement and barrier resolution, with software-only or service-supported delivery.

For a buyer, the choice is partly about operating capacity. Having a list of people who need help creates work. A platform becomes useful when someone has the time, authority and clinical support to act on that list.

Thirty-three percent, carefully

One AdhereHealth case study describes a southeastern regional health plan trying to reach high-risk members with diabetes and cardiovascular disease. The intervention prioritized people by their likelihood of nonadherence, then combined digital contact and live calls with coordination involving providers and pharmacists. Care navigators explored cost, access and medication confusion.

The distinction is small enough to miss and large enough to matter. A relative increase measures change against a starting value. A percentage-point increase measures the distance between two percentages. Neither should quietly turn into a claim about every member or every plan.

This is a vendor-published case involving an unnamed customer, rather than independent controlled evidence. It provides a concrete example of the strategy and its reported results. A prospective buyer should still examine the eligible population, the baseline, the people actually engaged and how the outcome was measured.

Who pays for the conversation?

AdhereHealth’s paying customers include managed care organizations, self-insured employers and other risk-bearing entities. Its programs address medication adherence, medication therapy management, preventive care and quality performance. For a health plan, better follow-through can matter to both member health and the economics of value-based reimbursement.

The published Resolve material makes the commercial idea unusually explicit: engagement fees are success-based, tied to gaps that are closed and maintained at a proportion of days covered of at least 80%. PDC is a refill-based measure of medication availability over time. A filled prescription offers evidence of access, although it cannot show every dose being swallowed.

The economic question therefore reaches beyond the cost of a call. What counts as success? How long must it last? Which population is being measured? An outcomes-based arrangement needs answers to those questions. The fee design creates a reason to follow through; the definition of the outcome determines what that reason rewards.

For members, the company says its support costs nothing through participating plans. Care navigators can help with refills, preventive appointments, benefits and community resources, using phone, text, mail and other channels. Someone receiving support is not necessarily shopping for another healthcare app. They may simply need an existing benefit to become usable.

A dispenser is only one part of the answer

In December 2021, AdhereHealth announced a partnership with Hero, whose connected dispenser sorts medication and tracks activity through an app. The agreement targeted vulnerable patients with complex regimens. Alerts could tell a care team about a missed dose or a coming refill.

A dispenser addresses the mechanics of a routine. Care coordination addresses the surrounding circumstances. The partnership illustrates why the company’s approach reaches across several types of intervention: different obstacles demand different responses. A device cannot settle a member’s concerns about treatment by itself.

That leadership announcement named Kempton Presley CEO and Patrick McNulty President and COO. Osborn’s role gives behavioral science a visible place in the executive team. The careers page also advertises fully remote positions and a nationally distributed workforce, a practical fit for a service delivered across health-plan populations.

The next refill is another test

“Robotic empathy is an oxymoron.”Kempton Presley · January 2026

Presley used that phrase in a company essay about the coming year. His argument was that technology should reduce low-value tasks and support human judgment. By September 2026, a podcast appearance was returning to the same question: how to balance technology with human engagement while taking responsibility for outcomes.

The lesson a reader can copy is operational. Give a risk signal an owner. Ask what prevents the next action. Connect that person with a resource that addresses the obstacle. Then check whether the solution survives the next refill, appointment or change in circumstances.

There are practical conditions attached. Incomplete claims can obscure the signal. A member who cannot be reached cannot explain the barrier. A navigator who identifies a transport problem still needs an available transport benefit or local resource. Counting an attempted call as a resolved problem would flatter the activity report while leaving the patient stranded.

Mr. Brooks’s story ends with medicine obtained and an exam completed. Its interesting feature is the work required to get there: several small arrangements, each removing a reason the next step might fail. AdhereHealth’s business depends on making those arrangements repeatable.